Counseling Points - March 2008 - (Page 2)

Faculty: Lynda S. Cook, RN, MSN, CRNI Greensboro, North Carolina Josephine C. Garnoc, RN, BSN, CCRN, CRNI Assistant Nurse Administration Manager Henry Ford Cottage Infusion Services Henry Ford Cottage Hospital Grosse Pointe Farms, Michigan Victoria Ruffing, RN Nurse Manager Johns Hopkins Arthritis Center Baltimore, Maryland Faculty Disclosure Statements: Lynda S. Cook has nothing to disclose. Josephine C. Garnoc has received honoraria as a presenter for Centecor and Genentech Inc. Victoria Ruffing has received honoraria as a consultant for Abbott Immunology, Amgen/Wyeth Pharmaceuticals, Bristol Myers Squibb, Genentech Inc., and Roche. Publishing Information: Publishers Joseph J. D’Onofrio Frank M. Marino Delaware Media Group 66 South Maple Avenue Ridgewood, NJ 07450 201-612-7676 Fax: 201-612-8282 www.delmedgroup.com Consulting Editor Kathleen Walther, RN, BSN, CRNI® Editorial Director Nancy Monson Medical Editor/Writer Kathryn Klobnak Art Director James Ticchio Cover photo credit: ©Diane Nelson/Custom Medical Stock Photo ©2008, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the Infusion Nurses Society, or Roche. Counseling Points™ Pharmacological and Nonpharmacological Treatment of Rheumatoid Arthritis Continuing Education Information Target Audience This educational activity is designed to meet the needs of infusion nurses and nurse practitioners involved directly in early and long-term management of patients with rheumatoid arthritis (RA). Learning Objectives Upon completion of this educational activity, the participant should be able to: • Discuss nonpharmacological rheumatoid arthritis (RA) treatment strategies • Review the benefits and limitations of nonsteroidal anti-inflammatory drug (NSAID) and corticosteroid therapy in RA • Describe the pharmacodynamics, administration, and adverse event profiles of currently available conventional and biologic disease-modifying antirheumatic drugs (DMARDs) Continuing Education Credit The Infusion Nurses Society (INS) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who practice in states that mandate continuing education for licensure are responsible for validating this education program with their state’s licensing board. INS is accredited as a provider of continuing nursing education by the California Board of Registered Nursing, Provider # CEP 14209. Nurses licensed by the California Board of Registered Nursing must retain their CE document for a period of 4 years. This continuing education activity is approved by the Infusion Nurses Certification Corporation (INCC) for 1 recertification unit. This continuing education activity is approved for 1.0 contact hour. This program expires March 31, 2010. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.The Infusion Nurses Society, Roche, and Delaware Media Group do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Infusion Nurses Society, Roche, or Delaware Media Group. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities. 2 COUNSELING POINTS™ http://www.delmedgroup.com

Table of Contents Feed for the Digital Edition of Counseling Points - March 2008

Counseling Points - March 2008 Welcome Pharmacological and Nonpharmacological Treatment of Rheumatoid Arthritis

Counseling Points - March 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.